We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Vaccine Design and Testing – Products

ProVir<sup>TM</sup>: Viral Antigen Bank content piece image
Product
Advertisement

ProVirTM: Viral Antigen Bank

The Native Antigen Company Wins ‘The Best COVID-19 Responder’ at OBN 2020 Awards content piece image
Product News

The Native Antigen Company Wins ‘The Best COVID-19 Responder’ at OBN 2020 Awards

The Native Antigen Company, part of LGC Clinical Diagnostics and a supplier of reagents that enables research into diagnostics and vaccines for emerging and endemic infectious diseases, won ‘The Best COVID-19 Responder’ at OBN 2020 Awards.
80+ Mutants From SARS-CoV-2 Variants of Concern content piece image
Product
Advertisement

80+ Mutants From SARS-CoV-2 Variants of Concern

ACROBiosystems has accelerated the development of a series of recombinant antigens of the SARS-CoV-2 Variants of Concern, including B.1.617, accordingly to help better understand the transmissibility and infectivity of the variant.
CleanCap® AG (3' OMe) Reagent: Next-Generation mRNA Capping Technology content piece image
Product
Advertisement

CleanCap® AG (3' OMe) Reagent: Next-Generation mRNA Capping Technology

CleanCap® enables a high-yield, streamlined manufacturing process that is cell-free and highly scalable for mRNA-based therapeutic and vaccine development.
CEPI Expands Global Footprint of Its COVID- 19 Vaccine Lab Network content piece image
Product News

CEPI Expands Global Footprint of Its COVID- 19 Vaccine Lab Network

The Coalition for Epidemic Preparedness Innovations, or CEPI, will expand its centralized laboratory network, a global initiative to harmonize the assessment of COVID-19 vaccine candidates undergoing testing, to also evaluate clinical trial samples against priority Variants of Concern.
UK Diagnostic Company Collaborates With UK Com-COV Vaccine Trial content piece image
Product News

UK Diagnostic Company Collaborates With UK Com-COV Vaccine Trial

Oxford Immunotec has announced that its T-SPOT® Discovery SARS-CoV-2 kit will be used for T cell testing in the UK Com-COV trial.
Best Practices for Vaccine Research content piece image
Whitepaper

Best Practices for Vaccine Research

Vaccination is largely recognized as the most cost-effective way to fight human infectious diseases. Vaccines play a vital role in immunization strategies that have helped to eradicate dangerous pathogens, increase human life expectancy and reduce disabilities and suffering all around the world.
Interrogate the SARS-CoV-2 Genome To Get More Answers content piece image
App Note / Case Study

Interrogate the SARS-CoV-2 Genome To Get More Answers

Studying the SARS-CoV-2 genome can provide valuable insights into its evolution and transmission, as well as aiding surveillance and vaccine development efforts to help control the COVID-19 pandemic. Download this app note to discover an RNA sequencing approach that can accurately identify low copy number viral pathogens.
ENPICOM and Viroclinics-DDL Partner To Accelerate and Improve Antibody and Vaccine Discovery and Development content piece image
Product News

ENPICOM and Viroclinics-DDL Partner To Accelerate and Improve Antibody and Vaccine Discovery and Development

Viroclinics-DDL and ENPICOM have announced the approval of their joint MIT Zuid subsidy (SME Innovation Stimulation Top Sectors South Holland) application.
Leinco Technologies and La Jolla Institute for Immunology To Develop Novel COVID-19 Diagnostic Tools content piece image
Product News

Leinco Technologies and La Jolla Institute for Immunology To Develop Novel COVID-19 Diagnostic Tools

La Jolla Institute for Immunology (LJI) has announced that it has signed a licensing agreement with Leinco Technologies, Inc. Leinco also provides custom manufacturing services to the diagnostic and biopharmaceutical industries to leverage proprietary COVID-19 antibodies developed at LJI.
Advertisement